NCT05633875View on ClinicalTrials.gov

Multimodal Imaging Signatures of the Biological Mechanisms Underlying Neurodegeneration in Multiple Sclerosis

RecruitingOBSERVATIONAL

Enrollment

80

Participants

Timeline

Start Date

March 23, 2023

Primary Completion Date

April 25, 2025

Study Completion Date

April 25, 2025

Conditions

Multiple Sclerosis (MS)

Interventions

OTHER

MRI

Patients will undergo MRI without contrast agent

Trial Locations (1)

75013

RECRUITING

CIC Neurosciences, Paris

All Listed Sponsors

lead

Assistance Publique - Hôpitaux de Paris

OTHER